Creating quick tests for certain fungal infections.
Official title: Development of rapid fungal diagnostics for select endemic dimorphic fungi
Funded at Immuno-Mycologics, INC. · NIH-10712501 · Data updated 2026-11-12
This study is working on creating quick tests that doctors can use right away to find certain fungal infections, helping patients get the right treatment faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Immuno-Mycologics, INC. NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2022 |
| Award (this year) | $1,499,709 |
| NIH project number | 75N93022C00027-0-9999-1 |
| Project ID | NIH-10712501 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are suspected of having infections caused by endemic dimorphic fungi.
✕Less likely to help
Patients with fungal infections not caused by the targeted endemic dimorphic fungi may not benefit from this research.
What this research studies
This research focuses on developing rapid diagnostic tests that can be used at the point of care to identify specific fungal infections caused by endemic dimorphic fungi. The approach aims to streamline the diagnostic process, allowing healthcare providers to quickly determine the presence of these infections and initiate appropriate treatment. By utilizing advanced diagnostic techniques, the research seeks to improve patient outcomes through timely and accurate detection of fungal diseases.
Why it matters
Potential benefit: If successful, this research could lead to faster diagnosis and treatment of fungal infections, potentially saving lives and reducing complications.
How similar studies have gone: Previous research has shown promise in developing rapid diagnostics for infectious diseases, indicating potential success for this approach.
Where this research is happening
-
Immuno-Mycologics, INC.
Norman, United States Active
Researchers
- Principal investigator: Konner, Scott — Immuno-Mycologics, INC.
- Study coordinator: Konner, Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.